CRP and neoplasm: This study is an exploratory research on the use of preoperative P-CRP levels as a blood marker for predicting the recurrence-free survival (RFS) of NMIBC patients after TURBT, and we included pathological data (including the number of tumors, tumor size, T staging, and G grading) in our predictive model.